GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Patient advocates have long pushed the Medical Board of California to share more information about potentially dangerous doctors.

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

Trump’s takeover has also led to the immediate departure of several high-ranking Kennedy Center appointments. Shonda Rhimes, ...

In the letter, Fairview says they told the University of Minnesota they are open to a partnership between the organizations ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Differently-abled lawyers in India face structural barriers—from inaccessible tech to limited opportunities in courts & law ...